In contrast, the other professors showed that FN1 expression correlated with the prognosis and degree of immune infiltration in thyroid cancer, suggesting that FN1 expression can be used as an immune-related biomarker and therapeutic target in thyroid cancer [24]. This evidence concerns the gene FN1 and thyroid gland carcinoma.